These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9548501)

  • 1. C1q augments platelet activation in response to aggregated Ig.
    Peerschke EI; Ghebrehiwet B
    J Immunol; 1997 Dec; 159(11):5594-8. PubMed ID: 9548501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
    Jiang HX; Siegel JN; Gewurz H
    J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of human platelets with particle-adherent aggregated IgG: description of the experimental system and role of C1q and monomeric IgG.
    Vollertsen RS; McDuffie FC; Bowie EJ
    Clin Exp Immunol; 1983 May; 52(2):423-9. PubMed ID: 6602680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody to the type II Fc receptor for human IgG blocks potentiation of monocyte and neutrophil IgG-induced respiratory burst activation by aggregated C-reactive protein.
    Zeller JM; Sullivan BL
    Cell Immunol; 1993 Jun; 149(1):144-54. PubMed ID: 8513509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement component C1q induces endothelial cell adhesion and spreading through a docking/signaling partnership of C1q receptors and integrins.
    Ghebrehiwet B; Feng X; Kumar R; Peerschke EI
    Int Immunopharmacol; 2003 Mar; 3(3):299-310. PubMed ID: 12639807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel 33-kDa C1q-binding site on human blood platelets.
    Peerschke EI; Reid KB; Ghebrehiwet B
    J Immunol; 1994 Jun; 152(12):5896-901. PubMed ID: 8207215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1Q, a subunit of the first component of complement, enhances the binding of aggregated IgG to rat renal mesangial cells.
    van den Dobbelsteen ME; van der Woude FJ; Schroeijers WE; Klar-Mohamad N; van Es LA; Daha MR
    J Immunol; 1993 Oct; 151(8):4315-24. PubMed ID: 8409404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
    Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
    Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of platelet aggregation induced by HLA-related antibodies.
    Brandt JT; Julius CJ; Osborne JM; Anderson CL
    Thromb Haemost; 1996 Nov; 76(5):774-9. PubMed ID: 8950789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein I.
    Arvieux J; Roussel B; Pouzol P; Colomb MG
    Thromb Haemost; 1993 Aug; 70(2):336-41. PubMed ID: 8236145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of thromboxane A2 and prostaglandin i2 affected by interaction of heat aggregated IgG, endothelial cells, and platelets in lupus nephritis.
    Kaneko N; Masuyama J; Nara H; Hirata D; Iwamoto M; Okazaki H; Minota S; Yoshio T
    J Rheumatol; 2002 Oct; 29(10):2106-13. PubMed ID: 12375319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fc gamma receptor-mediated interplatelet activation by a monoclonal antibody against beta 2 microglobulin.
    Rubinstein E; Boucheix C; Urso I; Carroll RC
    J Immunol; 1991 Nov; 147(9):3040-6. PubMed ID: 1833461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human blood platelets possess specific binding sites for C1q.
    Peerschke EI; Ghebrehiwet B
    J Immunol; 1987 Mar; 138(5):1537-41. PubMed ID: 3492557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet receptors for the complement component C1q: implications for hemostasis and thrombosis.
    Peerschke EI; Ghebrehiwet B
    Immunobiology; 1998 Aug; 199(2):239-49. PubMed ID: 9777409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet interactions with C1q in whole blood and in the presence of immune complexes or aggregated IgG.
    Peerschke EI; Ghebrehiwet B
    Clin Immunol Immunopathol; 1992 Apr; 63(1):45-50. PubMed ID: 1591882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic aggregation of human blood platelets and its inhibition in vitro].
    Malberg K; Elendt D; Elendt B
    Allerg Immunol (Leipz); 1986; 32(3):153-67. PubMed ID: 2947439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of Platelet Fc-receptor-dependent Response to Activating Monoclonal Antibodies.
    Mazurov AV; Vinogradov DV; Vlasik TN; Burns GF; Berndt MC
    Platelets; 1992; 3(4):181-8. PubMed ID: 21043876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1 and human platelets. III. Role of C1 subcomponents in platelet aggregation induced by aggregated IgG.
    Wautier JL; Souchon H; Solal LC; Peltier AP; Caen JP
    Immunology; 1976 Oct; 31(4):595-9. PubMed ID: 185144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of C1 subcomponents in platelet aggregation induced by aggregated IgG].
    Wautier JL; Souchon H; Peltier AP; Caen JP
    Ann Immunol (Paris); 1977; 128(1-2):81-2. PubMed ID: 848910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.